Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

ELL is crucial for gene transcription related to skin cell growth.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Low level laser or LED therapy combined with infiltrations may help hair growth.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

TRPM5 is crucial for maintaining hair growth.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Combining PRP with low-level laser therapy is better for hair growth than PRP alone.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Tet1/2/3 enzymes affect hair follicle cell development by influencing BMP signaling.

The assay effectively identifies compounds that affect immune cell activation.

Trps1 plays a key role in hair follicle development and cycling.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Lack of TrkC receptor delays hair follicle development.